PRESS RELEASES

EVQ%20green%20square_edited.jpg

30 June 2020

Eveliqure secures further private investment to support development of its combined Shigella and ETEC vaccine candidate
Read more

Calyxha square.png

20 April 2020

Calyxha Biotechnologies announces grant of a European Patent on neurodegenerative diseases
Read more

 

EVQ green square.png

5 November 2020

Eveliqure Biotechnologies GmbH announces a grant from the Wellcome Trust to support their effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries

Read more

CEBINA covid square.png

4 June 2020

CEBINA secures seed funding for its unique extended spectrum Coronavirus vaccine
Read more

CEBINA covid square.png

17 April 2020

CEBINA today announces the initiation of several collaborative projects that address the global health crisis caused by the pandemic spread of the SARS-CoV-2 virus
Read more

EVQ green square.png

2 June 2020

Eveliqure Biotechnologies announces regulatory approval to initiate first clinical trial of its ShigETEC vaccine candidate Biotechnologies 
Read more

Calyxha square.png

4 March 2020

Calyxha Biotechnologies announces new financing to support pre-clinical development of its therapeutic lead candidate, CAL-X
Read more